Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France.

PHASE4CompletedINTERVENTIONAL
Enrollment

7,204

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

December 31, 2010

Study Completion Date

June 30, 2011

Conditions
Rotavirus Gastroenteritis
Interventions
BIOLOGICAL

Rotateq vaccine

"Vaccination against rotavirus~Three oral doses (2 mL) between 6 to 26 weeks of life with at least 4 weeks between each dose."

Trial Locations (1)

29200

Clinical Investigation Center, Brest

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

MCM Vaccines B.V.

INDUSTRY

lead

University Hospital, Brest

OTHER

NCT00740935 - Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France. | Biotech Hunter | Biotech Hunter